CUMBERLAND, R.I., March 12, 2026--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc. (the "Company") today provided an update on its ongoing transition to a commercial‑stage company following the first ...
Please provide your email address to receive an email when new articles are posted on . “The entire Neurotech family mourns this loss,” the company said in a statement. “On behalf of the board of ...
Neurotech Pharmaceuticals, Inc. (the "Company") today provided an update on its ongoing transition to a commercial--stage company following the first anniversary of the FDA's approval of ENCELTO(TM) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results